Aerie Pharmaceuticals competitive analysis

Latest publications and patents of Aerie Pharmaceuticals New

Explore the latest publications and patents granted to Aerie Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aerie Pharmaceuticals

Feb 22, 2023Compound For Use In The Treatment Of Ocular DisordersGranted And Under Opposition
Jun 9, 2021Combination TherapyGranted And Under Opposition

Explore Aerie Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 22, 2023Compound For Use In The Treatment Of Ocular Disorders3
Jun 9, 2021Combination Therapy3

Latest PTAB cases involving Aerie Pharmaceuticals

Discover the latest PTAB cases involving Aerie Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aerie Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
AERIE PHARMACEUTICALS - 6 - - Non-Active
ALFRED E TIEFENBACHER443 - - Highly Aggressive
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB12 - - - Highly Aggressive
GENERICS UK212 - - - Highly Aggressive